Allergan Shareholders Green Light AbbVie Takeover
Allergan Shareholders Green Light AbbVie Takeover
GALWAY, IRELAND--October 28, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Shareholders at Botox-maker Allergan plc (NYSE:AGN) (Dublin, Ireland) have voted to approve a proposed $63 billion takeover by pharmaceutical major AbbVie (NYSE:ABBV) (Chicago, Illinois).
Within this article: Details positive shareholder reaction to the takeover, value of the deal, key products and players
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion